Glomus tumor of the trachea.

Asian Cardiovasc Thorac Ann

Department of General Surgery, Emam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.

Published: March 2015

Glomus tumors of the trachea are rare and benign, but most become symptomatic, so they need intervention. A 21-year-old man was evaluated due to cough and hemoptysis. Computed tomography and bronchoscopy showed a polypoid mass above the carina. The tumor was removed completely by rigid bronchoscopy. The pathologic diagnosis was glomus tumor. After one year, because of recurrence of the tumor at the same site, the patient underwent reoperation, and resection and anastomosis of trachea through a right posterolateral thoracotomy was performed.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0218492314528184DOI Listing

Publication Analysis

Top Keywords

glomus tumor
8
tumor trachea
4
trachea glomus
4
glomus tumors
4
tumors trachea
4
trachea rare
4
rare benign
4
benign symptomatic
4
symptomatic intervention
4
intervention 21-year-old
4

Similar Publications

Glomus Tumor in the Left Submandibular Region: A Rare Case Report and Literature Review.

Cancer Rep (Hoboken)

January 2025

Department of Dermatology, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China.

Background: Glomus tumors are rare, benign mesenchymal neoplasms predominantly located in subungual regions of the extremities. Their occurrence in the mandibular region is exceptionally uncommon, presenting unique diagnostic challenges. Only a limited number of submandibular glomus tumors have been documented, leaving their presentation and management largely underexplored.

View Article and Find Full Text PDF

Introduction: Glomus tympanicum is a benign tumor classified under the group glomus tumors, and is also known as paragangliomas.

Case Presentation: A 52 years old woman presented with unilateral pulsatile tinnitus and hearing loss. She had a visible reddish mass behind the eardrum; Temporal bone CT scans suggested middle ear mass secondary to Glomus Tympanicum tumors.

View Article and Find Full Text PDF

Successful Multi-Modal Laser Intervention and Histopathological Evaluation of Multiple Glomangiomas.

Lasers Surg Med

December 2024

Department of Dermatology, Veterans Health Administration, San Antonio, Texas, USA.

Objectives: Glomangiomas are benign vascular malformations that exist within the spectrum of glomuvenous malformations which consist of varying amounts of glomus cells, vascular spaces, and smooth muscle. Glomangiomas are often treated due to associated pain, particularly when located on pressure areas such as the back or extensor surfaces, which can cause difficulty with certain activities and occupational functions. Histologically glomangiomas consist of prominent dilated vascular spaces lined by glomus cells typically situated in the deep-dermis to subcutaneous fat which limits treatment to modalities capable of reaching the depth of the tumor including excision, sclerotherapy, and laser therapy.

View Article and Find Full Text PDF

Juxtaglomerular cell tumor (JxGCT) is a rare type of renal neoplasm demonstrating morphologic overlap with some mesenchymal tumors such as glomus tumor (GT) and solitary fibrous tumor (SFT). Its oncogenic drivers remain elusive, and only a few cases have been analyzed with modern molecular techniques. In prior studies, loss of chromosomes 9 and 11 appeared to be recurrent.

View Article and Find Full Text PDF

Introduction: The ZAP-X® Gyroscopic Radiosurgery System (ZAP Surgical Systems, Inc., San Carlos, CA, USA) is expected to be a highly accurate next-generation treatment system that enables gyro-stereotactic irradiation of intracranial lesions. In this study, we report the initial treatment course using ZAP-X for intracranial lesions that recurred after Gamma Knife (GK) treatment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!